Stock Taper Revenue Before Reimbursable Expenses (RBR):: $443.7 million, up 12.1% from $395.7 million in Q1 2025.
Net Income:: $23.2 million ($1.34 per diluted share) compared to $24.5 million ($1.33 per diluted share) in Q1 2025.
Adjusted EBITDA:: $50.6 million (11.4% of RBR), up from $41.5 million (10.5% of RBR) in the prior year.
Effective Tax Rate:: 14.1%, compared to a negative 14.4% in Q1 2025.
Free Cash Flow:: Negative $174 million due to annual incentive payments; expected full-year positive free cash flow of $180 million to $220 million.
Days Sales Outstanding (DSO):: Increased to 82 days from 79 days in Q1 2025, attributed to larger Healthcare projects.
Segment Performance::
Healthcare:: RBR grew 14% year-over-year, driven by strong demand for performance improvement and revenue cycle services.
Education:: RBR increased by 4%, supported by digital offerings despite challenges in international student enrollment.
Commercial:: RBR surged 22%, reflecting strong demand for financial advisory services.
AI Integration:: Continued investment in AI capabilities is expected to drive future growth, with a focus on integrating AI into client solutions.
Share Repurchase Program:: $155.5 million used to repurchase 1.1 million shares, representing 6.5% of outstanding shares.
2026 Guidance Affirmation:: RBR expected to be between $1.78 billion and $1.86 billion, with adjusted EBITDA margin of 14.5% to 15% and adjusted EPS of $8.35 to $9.15.
Long-term Growth Strategy:: Commitment to low double-digit revenue growth and margin expansion, supported by a disciplined capital allocation strategy.
Declining Metrics:: Net income margin decreased to 5.1% from 6.1% in the prior year, primarily due to a higher effective tax rate.
Increased DSO:: The rise in DSO indicates potential cash flow challenges related to larger project timelines.
Market Pressures in Education:: Higher education institutions face rising operational costs and declining student enrollment, which could impact future demand.
Pipeline Development:: Bookings increased over 20% across all segments, with backlog at historically high levels.
Segment-Level Growth:: Digital capabilities in Healthcare saw a decline of 7%, while Commercial Consulting grew approximately 50% organically.
Headcount Growth:: Significant hiring in Healthcare to meet demand; expectations for normalization in headcount growth moving forward.
AI Market Position:: Huron is confident in its organic capabilities to address the growing AI services market, with a focus on internal talent rather than acquisitions. Overall, Huron Consulting Group reported a solid start to 2026, with strong revenue growth across segments and a reaffirmed positive outlook, despite facing challenges in net income margins and cash flow management.
SOURCE: Q1 2026 EARNINGS CALL TRANSCRIPT